May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Persistent secretion of vascular endothelial growth factor into vitreous cavity in proliferative diabetic retinopathy after vitrectomy
Author Affiliations & Notes
  • H. Itakura
    Ophthalmology, Gunma Univ Sch Med, Maebashi–Shi, Japan
  • S. Kishi
    Ophthalmology, Gunma Univ Sch Med, Maebashi–Shi, Japan
  • Footnotes
    Commercial Relationships  H. Itakura, None; S. Kishi, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4159. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Itakura, S. Kishi; Persistent secretion of vascular endothelial growth factor into vitreous cavity in proliferative diabetic retinopathy after vitrectomy . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4159.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Rubeotic glaucoma is a frequent complication after vitrectomy for proliferative diabetic retinopathy (PDR). To assess the level of vascular endothelial growth factor (VEGF) in the vitreous fluid obtained at vitreous surgery and at postoperative fluid air exchange. Methods: Using ELISA, we measured VEGF level in vitreous samples from 17 eyes of 15 patients with PDR during vitrectomy and fluid samples obtained from fluid air exchange at 5–36 postoperative days. Six of the 17 eyes developed rubeosis after vitrectomy. VEGF level was also examined in the vitreous fluid obtained from 8 eyes with macular hole at vitrectomy and postoperative fluid air exchange. We measured the plasma VEGF level in all patients. Results: VEGF level in 17 eyes with PDR was1162.3±173.2 pg/ml in the vitreous sample and 1180.4±182.8 pg/ml in the postoperative fluid sample. The plasma VEGF level was 116.1±10.2 pg/ml in PDR. In 8 eyes with macular hole, VEGF level was 96.9±11.5 pg/ml in the vitreous sample and 73.9±12.3 pg/ml in the fluid sample. The plasma VEGF level was 118.5±15.2pg/ml. VEGF level was much higher in PDR than that in macular hole in the vitreous samples (p<0.00005) as well as in the fluid samples (p<0.0001). The VEGF level in the vitreous samples were significantly related to those in the postoperative fluid samples (r=0.790, p<0.0005). Conclusions: High VEGF level was maintained in the vitreous cavity after vitrectomy for PDR. The VEGF level in PDR was 10 times higher than that of the plasma. The results suggested the persistent secretion of VEGF into the vitreous cavity even after vitrectomy in PDR.

Keywords: diabetic retinopathy • vitreous • neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×